Loading…
5 companies · GEL, thousands · columns ordered by revenue
GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series
| Metric | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 360 | 340 | 782 | 698 | 2,602 | 2,926 | 1,976 | 1,845 |
| EBITDA | 753 | -4 | 139 | 57 | 488 | 409 | 449 | 118 |
| Net profit | 1,221 | -0 | 112 | 17 | 469 | 57 | -629 | 381 |
| Total assets | 1,263 | 1,250 | 2,898 | 3,339 | 5,538 | 6,303 | 6,660 | 4,663 |
| n (companies reporting) | 1 | 1 | 2 | 3 | 5 | 5 | 5 | 5 |
GEL, thousands
| Company | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|---|
| MD Group | — | — | — | — | 0 | 829 | 675 | 512 |
| MedX | — | — | 492 | 416 | 449 | 513 | 457 | 494 |
| Me-11 Kalta Konsultatsia | — | — | — | — | 0 | 471 | 340 | 348 |
| Tbilisis 25-E Mozrdilta… | 360 | 340 | 290 | 282 | 356 | 332 | 300 | 303 |
| Lilos Sameditsino Tsent… | — | — | — | 0 | 1,797 | 781 | 204 | 188 |
Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.
Peer coverage varies by year — FY2017–FY2021 pool fewer than the 5 picked companies (see the n row). A year is never dropped because one peer is missing.
Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.